» Articles » PMID: 7060853

The Bedford Survey: Ten Year Mortality Rates in Newly Diagnosed Diabetics, Borderline Diabetics and Normoglycaemic Controls and Risk Indices for Coronary Heart Disease in Borderline Diabetics

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1982 Feb 1
PMID 7060853
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Mortality rates from coronary heart disease and from all causes have been ascertained over ten years in three groups of people participating in the Bedford Survey--newly-diagnosed diabetics, borderline diabetics and control subjects with normal glucose tolerance. Age corrected mortality rates, from all causes and coronary heart disease, were highest in the diabetics and intermediate in the borderline diabetics and in both groups were similar in men and women. When statistical allowance was made for baseline differences in age, blood pressure and obesity, female borderline diabetics still had a significantly increased risk over their controls of death from 'all causes'. Much of the difference appeared to be due to a relative excess of deaths due to coronary heart disease. It is concluded that borderline diabetes (or impaired glucose tolerance) is associated with a relatively greater increase in mortality risk in women than men. During the 10-year follow-up of the Bedford borderline diabetics, coronary heart disease morbidity and mortality rates were similar in men and women. Age at entry to the study was the major independent and significant predictor of mortality from all causes. The level of systolic blood pressure and current cigarette smoking at baseline were statistically significant predictors only of mortality due to coronary heart disease.

Citing Articles

"Hyperglycemic Memory": Observational Evidence to Experimental Inference.

Ahmadi M, Ghafouri-Fard S, Najari-Hanjani P, Morshedzadeh F, Malakoutian T, Abbasi M Curr Diabetes Rev. 2024; 21(4):64-78.

PMID: 38369731 DOI: 10.2174/0115733998279869231227091944.


Potential of gut microbiota for lipopolysaccharide biosynthesis in European women with type 2 diabetes based on metagenome.

Dong Y, Wang P, Yang X, Chen M, Li J Front Cell Dev Biol. 2022; 10:1027413.

PMID: 36303603 PMC: 9592851. DOI: 10.3389/fcell.2022.1027413.


Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis.

Xu G, You D, Wong L, Duan D, Kong F, Zhang X Eur J Endocrinol. 2019; 180(4):243-255.

PMID: 30668524 PMC: 6391911. DOI: 10.1530/EJE-18-0792.


Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Richter B, Hemmingsen B, Metzendorf M, Takwoingi Y Cochrane Database Syst Rev. 2018; 10:CD012661.

PMID: 30371961 PMC: 6516891. DOI: 10.1002/14651858.CD012661.pub2.


Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients.

Kim Y, Lee J, Kang H, Park S Sci Rep. 2018; 8(1):12190.

PMID: 30111867 PMC: 6093904. DOI: 10.1038/s41598-018-30740-y.


References
1.
Fuller J, Shipley M, Rose G, Jarrett R, Keen H . Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980; 1(8183):1373-6. DOI: 10.1016/s0140-6736(80)92651-3. View

2.
Keen H, Chlouverakis C, Fuller J, Jarrett R . The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep. 1969; 118(2):247-54. View

3.
Walker S, Duncan D . Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967; 54(1):167-79. View

4.
Jarrett R, Keen H, Fuller J, McCartney M . Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin. Br Med J. 1977; 2(6091):861-5. PMC: 1631655. DOI: 10.1136/bmj.2.6091.861. View

5.
. Asymptomatic hyperglycemia and coronary heart disease. A series of papers by the International Collaborative Group, based on studies in fifteen populations. Introduction. J Chronic Dis. 1979; 32(11-12):683-91. DOI: 10.1016/0021-9681(79)90047-x. View